Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

The state of Maryland and the Moore Administration can best be characterized as “whistling past the graveyard” once again … case in point: The Virginia Mercury headline (July 22, 2025) … “AstraZeneca ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

ROCKVILLE, Md. and SUZHOU, China ... and other relationships with numerous leading biotechnology and pharmaceutical companies, such as Takeda, AstraZeneca, Merck, Pfizer, and Innovent, in addition to ...

AstraZeneca has revealed plans to invest $50bn in the US by 2030 with the aim of reaching $80bn in total revenue by 2030, ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and Presiden… ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to ...

AstraZeneca announces that it will invest $50 billion in the U.S. by 2030, including a multi-billion-dollar manufacturing site in Virginia.